Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Dyslipidaemia: PCSK9 antibodies: a dividend of the genomics revolution.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Dyslipidaemia: PCSK9 antibodies: a dividend of the genomics revolution.
Dyslipidaemia: PCSK9 antibodies: a dividend of the genomics revolution. Nat Rev Cardiol. 2013 Nov; 10(11):618-9.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Anticholesteremic Agents
Azetidines
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypercholesterolemia
Male
Proprotein Convertases
authors with profiles
Michael H. Davidson